Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department has (a) sought and (b) received advice from immunologists on the effectiveness of Evusheld.

The Government’s decision not to procure Evusheld at this time was based on independent clinical advice by the multi-agency RAPID C-19 . DHSC also sought advice from a United Kingdom national expert policy working group, which includes a range of expertise including immunology, virology and relevant specialisms such as oncology. The membership of these groups also included experts in interpreting and analysing complex data, including clinicians and pharmacists, evidence assessors, and researchers.